The U.K. is under pressure to offer a better deal to global pharmaceutical firms, as a slew of pulled investments and stalled drug pricing talks loom over U.S. President Donald Trump’s state visit to Britain. Drug companies have been urging U.K. authorities to pay more for drugs and improve the competitive landscape ahead of a…
London’s FTSE 100 touched a fresh record high on Friday – and some market watchers see more upside ahead for the long-maligned index, with U.S. tariffs, macroeconomic influences and outperformance in certain sectors sparking a widespread reassessment of U.K. equities. The U.K. index — home to some of the world’s most renowned companies, including AstraZeneca…
AstraZeneca CEO Pascal Soriot, pictured in London on June 28, 2023, reportedly wants to move the company’s stock listing from London to the United States. Justin Tallis | Afp | Getty Images Pressure is piling on London’s stock exchange, with reports that British pharma giant AstraZeneca may move its listing to the U.S. delivering yet…